Dr Seth Berkley appointed new GAVI CEO

The GAVI Alliance Board said it appointed Dr Seth Berkley as GAVI’s new CEO. Dr. Berkley is currently President, CEO and founder of the International AIDS Vaccine Initiative (IAVI). Dagfinn Høybråten, GAVI Alliance Board Chair, commented, “The GAVI Board is delighted to have attracted such a highly qualified and charismatic individual as Dr Berkley. (He) is an experienced leader in global public health with strong advocacy skills and is highly motivated to making vaccines available for all children. I am confident that, with Dr Berkley as the CEO, the Alliance will further increase its crucial role in providing cost effective immunisation for the world’s disadvantaged.”  Dr Berkley is expected to take up his new role in August but will participate in several key GAVI meetings, including the Alliance’s first pledging conference on 13 June, which will be hosted by the UK government.

Dr Berkley commented, “I am very familiar with GAVI’s life-saving work and have great admiration for its successful track record. I am, therefore, honored and extremely excited to have been chosen to lead the Alliance as it works to deliver on an ambitious new strategy to introduce new vaccines including those against pneumococcal and rotavirus diseases, Meningitis A, HPV, rubella and Japanese encephalitis. I also look forward to the day when malaria and HIV will be added to this list.”